Find Academic Supervisors

Niklas WahlbergView profile

Professor

• Lepidoptera Evolution
• Molecular Systematics
• Biogeography
• +5 more

Niklas Wahlberg is a Professor in Biological Systematics at Lund University, Sweden. He holds roles including Museum Director of the Biological Museum and Principal Investigator in the BECC biodiversity initiative. His primary affiliation is with the Department of Biology, focusing on evolutionary biology and systematics of Lepidoptera. Education & Career: PhD in Evolutionary Biology from University of Helsinki (2000) Postdoc at Stockholm University (2000–2002) Academy Research Fellowship at University of Turku (2006–2011) Professor in Genetics at Turku (2014) before moving to Lund in 2015 Research Interests: His work centers on the evolutionary history of Lepidoptera, particularly diversification patterns linked to angiosperm evolution and mass extinction events. He employs molecular systematic methods, next-gen sequencing, and museum specimens to study clade origins and biogeography. Key topics include Cretaceous diversification, post-mass extinction radiation, and genomic discordance in butterflies. Awards & Recognition: Web of Science Highly Cited Researcher (2017, 2018) Elected to Kungliga Fysiografiska Sällskapet (2016) Grants & Projects: Swedish Research Council: Testing gene-trait associations in genome modifications (2025–2029) Infrastructure leader for museum collections and holistic specimen projects Labs & Collaborations: Head of the Systematic Biology Group at Lund, managing the Biological Museum’s collections. Active in global entomology networks and co-organizes major conferences like the International Congress of Entomology.

• Program Verification
• Proof Engineering
• Formal Methods
• +4 more

Karl Palmskog is a Lecturer at KTH Royal Institute of Technology in the Division of Theoretical Computer Science and the STEP research group. His work focuses on program verification and proof engineering, with particular emphasis on developing techniques and tools based on proof assistants for constructing functionally correct and secure software systems. Palmskog received his Ph.D. in Computer Science in 2014 from KTH, advised by Mads Dam, and his M.Sc. in Computer Science and Engineering from KTH in 2007. Prior to his current position, he was a postdoc at The University of Texas at Austin and University of Illinois at Urbana-Champaign. His research interests span programming languages, software engineering, and formal verification, with a particular focus on developing techniques and tools based on proof assistants. He is an avid user of the Coq proof assistant for both proving and programming, often complemented by OCaml, and also utilizes HOL4 and other ML family dialects. His work bridges theoretical foundations with practical applications, particularly in the domains of blockchain systems, distributed systems, and automotive software verification. Analysis of his recent publications reveals a strong focus on Coq-based verification, with significant contributions to proof engineering tools and methodologies. His work includes developing tools for regression proving, change impact analysis, mutation testing for Coq projects, and lemma name suggestion using deep learning. There's also a growing trend toward applying formal methods to real-world systems like blockchain protocols and automotive software. Palmskog has been involved in several research projects, including Coq-community Proof Engineering and Distributed Components. His past projects include Trustfull (SSF), Model-based Event Driven Scalable Programming for the Mobile Cloud (NSF), Highly Adaptable and Trustworthy Software (EU FP7), and 4WARD Future Internet (EU FP7). As an educator, Palmskog has served as examiner, course responsible, teacher, and assistant for various courses including Algorithms, Data Structures and Complexity; Degree Projects; Game Theory; Parallel and Distributed Computing; and Programming Paradigms. His work on Chip, a Coq formalization of change impact analysis, demonstrates his commitment to creating practical, certified tools that bridge formal methods with software engineering practice.

• Hematology
• Clinical Chemistry
• Hemostasis and Thrombosis
• +7 more

Jovan P. Antovic is a Professor of Clinical Chemistry and Coagulation at the Department of Molecular Medicine and Surgery, Karolinska Institutet, a position he has held since May 1, 2022. He combines his professorship with a role as Chief Physician at the Medical Unit for Clinical Chemistry, Karolinska University Laboratory, Karolinska University Hospital. He leads the Clinical Chemistry and Coagulation research group and manages the KARMITH Core Facility (Karolinska Microscopic Imaging in Thrombosis & Hemostasis). Additionally, he serves as a Visiting Professor of Hematology at the Faculty of Medicine Nis and Kragujevac in Serbia. Dr. Antovic received his medical degree in 1993 and specialist degree in Internal Medicine - Hematology in 1998 from the University of Nis, Serbia. He earned his PhD in coagulation/clinical chemistry from Karolinska Institutet in 2003 and became a specialist in Clinical Chemistry in 2011. He achieved Docent status (equivalent to Associate Professor) at Karolinska Institutet in 2009. His research focuses on hemostasis and thrombosis, particularly studying the utility of global hemostatic methods and microparticles as potential biomarkers for diagnosis, prognosis, and treatment monitoring in clinical conditions associated with bleeding or thrombotic tendencies. He has a special focus on cardiovascular status in aging hemophilia patients. His work spans several areas including hemophilia research, diagnosis of Von Willebrand's disease, laboratory diagnostics of microangiopathies, and monitoring of direct oral anticoagulants. Analysis of his publication history reveals a consistent focus on improving diagnostic methods for coagulation disorders, with particular emphasis on hemophilia management and the application of global hemostatic assays. His research bridges basic science with clinical applications, focusing on translating laboratory findings into improved patient care. Dr. Antovic has authored or co-authored more than 80 peer-reviewed publications and co-edited two editions of the 'Essential Guide to Blood Coagulation.' He serves on the Editorial Board of the Journal of Thrombosis and Haemostasis and is a Review Editor for Thrombosis in Frontiers in Cardiovascular Medicine. Dr. Antovic actively supervises multiple PhD students and post-docs, including Maria Farm (working on venous thromboembolism), Yanan Zong (focusing on aging hemophilia patients), Roza Chaireti (studying hemophilia A with inhibitors), Maria Magnusson (researching liver disease-related hemostatic disturbances), and Iva Pruner (developing microparticle immunolabeling techniques). His research is supported by various grants, including collaborations with the University of Kragujevac in Serbia. He leads the KARMITH Core Facility, which provides microscopic imaging services for thrombosis and hemostasis research, and is involved in multiple national and international projects focusing on both thrombosis and bleeding disorders.

• Cell and Molecular Biology
• Endocrinology and Diabetes
• Pediatrics
• +7 more

Svetlana Lajic is an Adjunct Professor in Pediatric Endocrinology and Inherited Metabolic Diseases at the Department of Women's and Children's Health, Karolinska Institutet , and a Senior Consultant at Karolinska University Hospital, Stockholm, Sweden. She serves as the European Pediatric Chair for the adrenal thematic group in Endo ERN and contributes to the Swedish Pediatric Association as Treasurer. Her research focuses on cognitive functioning and brain development in individuals with rare endocrine disorders, including Congenital Adrenal Hyperplasia (CAH) and Addison's Disease , investigating the long-term effects of prenatal dexamethasone treatment and epigenetic alterations . She leads studies on metabolic outcomes, neural connectivity, and quality of life in patients with inborn errors of metabolism (IEM). Key Research Areas: Cognitive and brain development in CAH and Addison's Prenatal dexamethasone treatment safety Epigenetic effects of glucocorticoid exposure Neonatal screening for IEM Clinical Roles: Senior Consultant, Pediatric Endocrinology European Pediatric Chair, Endo ERN adrenal group

Trung Nghia VuView profile

Researcher

• Bioinformatics
• Computational Biology
• Cancer Genomics
• +5 more

Trung Nghia Vu is a Principal Researcher at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden. His research group focuses on developing and applying statistical and bioinformatics methods for molecular biology and medicine, with particular emphasis on cancer genomics and pharmacogenomics. Dr. Vu received his PhD from the Department of Mathematics and Computer Science at the University of Antwerp, Belgium (2009-2014), following an MSc in Computer Engineering from Korea Aerospace University (2006-2008) and a BSc in Technology from Vietnam National University in Hanoi (2000-2004). His research focuses on developing statistical and bioinformatics methodologies for analyzing high-throughput omics data, with specific interests in single-cell sequencing analysis, characterization of cancer omics, and pharmacogenomics. His group has developed 20 statistical and bioinformatics tools available through Biostat Wiki Primary research areas include gene/isoform quantification, detection of abnormal RNAs, single-cell RNA-seq analysis, and drug response prediction Current projects focus on breast cancer and Acute Myeloid Leukemia (AML) Analysis of Dr. Vu's recent publications reveals a strong focus on cancer genomics, particularly in AML and breast cancer. His work bridges computational biology with clinical applications, developing methods for spatial transcriptomics, drug synergy prediction, and circular RNA analysis. The research demonstrates a clear trajectory toward precision medicine applications, with increasing emphasis on personalized drug response prediction and pathway activation modeling. Dr. Vu actively supervises multiple students and researchers, including both completed PhD students (Quang Thinh Trac, Lu Pan, Wenjiang Deng) and ongoing supervisees (Gulser Caliskan, Meghana Alugunoolla, Yuying Li, Aron Arzoomand). His research is supported by significant grants from the Swedish Research Council, CancerFonden, and Karolinska Institutet. He leads the Computational Medicine and Bioinformatics research group at Karolinska Institutet, which collaborates with international clinical and systems-biology researchers. The group maintains active development of bioinformatics tools and maintains the Biostat Wiki platform for academic use. Dr. Vu also contributes to teaching through master's and doctoral courses in biostatistics and R programming at Karolinska Institutet.

Marcus Fager FerrariView profile

Clinical Professor

• Hematology
• Gene
• Sialylation
• +6 more

Marcus Fager Ferrari is a Clinical Professor affiliated with the Faculty of Medicine at Lund University, specializing in Hematology and clinical coagulation research in Malmö. His work intersects genetics, molecular biology, and clinical diagnostics, focusing on inherited bleeding disorders, collagen-related gene variants, and platelet biology. Research Interests: His research spans hematology, genetic screening, and molecular mechanisms of bleeding disorders, including studies on collagen remodeling, sialylation pathways, and GNE-associated thrombocytopenia. He investigates the role of ascorbic acid in coagulation and employs sialidase inhibitors like oseltamivir for therapeutic exploration. Academic Activities: In 2023, he participated as an invited speaker in a seminar on Chronic Myeloid Leukemia organized by LUCC (Lund University Cancer Centre). His recent publications (2021-2024) highlight expertise in monoclonal gammopathy, hemostasis, and genetic diagnostics.

• Antibiotic Resistance
• Influenza Virus Research
• One Health Approach
• +3 more

Josef Järhult is a Professor at Uppsala University's Faculty of Medicine, holding dual appointments in the Department of Medical Sciences (Infectious Diseases) and as a Guest Researcher in the Department of Medical Biochemistry and Microbiology. His work spans multiple disciplines with a focus on the intersection of human, animal, and environmental health. At the Academic Hospital, he works in the Infection department (entrance 34, 1st floor), and at the university, he is based at BMC Husargatan 3 in Uppsala. Dr. Järhult's research program centers on antibiotic resistance mechanisms and transmission, particularly examining the environmental dimension of antimicrobial resistance. His work frequently employs the One Health framework, investigating connections between human medicine, veterinary science, and environmental factors. Key areas include the study of ESBL-producing bacteria in water systems, influenza virus transmission between species, and antimicrobial resistance patterns across different settings including hospitals, farms, and wildlife. His laboratory work often involves genomic analysis of resistant pathogens and examination of resistance gene transmission across human-animal-environment interfaces. Analysis of his recent publications reveals a strong emphasis on spatial and temporal patterns of antimicrobial resistance, with significant work conducted in Sweden and Southeast Asia. His research program demonstrates consistent productivity with publications spanning clinical infectious diseases, environmental microbiology, and translational research connecting laboratory findings to public health implications. The work often involves international collaborations across Europe, Southeast Asia, and North America. Dr. Järhult has contributed significantly to understanding how antimicrobial resistance develops and spreads in natural environments, particularly examining the role of water systems and wildlife as reservoirs and vectors for resistant bacteria. His work on influenza viruses in waterfowl has provided important insights into viral evolution and transmission dynamics between wild birds and domestic animals.

• Software Engineering
• Software Testing
• Mutation Analysis
• +2 more

András Márki is a Lecturer at the University of Skövde , affiliated with the School of Informatics and the Department of Information Technology . His work focuses on software testing , mutation analysis , and reliable software verification . Education: Course Coordinator for multiple bachelor-level courses (7.5–30 credits). Research: Lead author on DOMINO , a project reducing software mutation complexity (2017–2025). Publications: Explored topics like strong mutation, redundant mutants, and Java-based tools (2015–2020).

Linus SandegrenView profile

Professor

• Antibiotic Resistance
• Molecular Evolution
• Bacterial Genetics
• +3 more

Linus Sandegren is a Professor at Uppsala University , affiliated with the Department of Medical Biochemistry and Microbiology and the Uppsala Antibiotic Center . His research focuses on the molecular mechanisms of antibiotic resistance, particularly the evolution and dissemination of resistance plasmids in pathogenic bacteria. Department of Medical Biochemistry and Microbiology Uppsala Antibiotic Center His work spans antibiotic resistance , molecular evolution , and bacterial genetics , with a strong emphasis on plasmid stability, mobility, and fitness costs. Recent publications highlight his contributions to CRISPR-based resistance prevention , optical DNA mapping , and nano-biosensor development for rapid resistance gene detection. Key article trends include: Antibiotic resistance gene transfer Plasmid-mediated resistance mechanisms Novel diagnostic technologies Biofilm evolution and virulence adaptation Environmental reservoirs of resistance Antibiotic combination efficacy He actively collaborates on antibiotic resistance research and has contributed to policy discussions through publications in Science of the Total Environment and Upsala Journal of Medical Sciences . No formal students are listed in the provided materials.

• Breast Cancer
• Ovarian Cancer
• Genetic Counseling
• +3 more

Niklas Loman is an Associate Professor and Principal Investigator at the Lund University Cancer Centre (LUCC), affiliated with Lund University. His primary roles include Consultant, Project Manager, and Supervisor in breast/ovarian cancer research. Research Focus: Loman’s work centers on breast and ovarian cancer, particularly BRCA1/2 mutations, genetic testing, immunometabolism dynamics, and clinical trial design. His contributions include the Sweden Cancerome Analysis Network-Breast (SCAN-B) initiative, a large-scale genomic analysis platform, and the NordicTrip phase III trial exploring chemotherapy combinations for triple-negative breast cancer. Publications & Projects: With 127 publications, his recent work includes studies on estrogen receptor-low breast cancers, longitudinal immunometabolic profiling, and genetic testing guidelines. Active projects include NordicTrip (2024–2029) and SCAN-B (since 2009), focusing on genomic insights and clinical implementation. Awards & Recognition: While no specific awards are listed, his contributions to breast cancer genomics and clinical trials reflect significant academic impact. Grants & Teams: Funded by Cancerfonden and Mrs. Berta Kamprad’s Cancer Foundation, Loman collaborates on translational research and organizes events like the LUCC Breast Retreat and seminars on HER2-positive/triple-negative cancers.

Isa TasView profile

Research Fellow

• Cancer and Oncology
• Cell and Molecular Biology
• Basic Cancer Research
• +8 more

Isa Tas is a Postdoctoral Fellow at Lund University , affiliated with the Division of Translational Cancer Research under the Faculty of Medicine and the Lund University Cancer Centre (LUCC) . Her research focuses on Lung Cancer , Drug Discovery , and Organoid Technology , with contributions to Colorectal Cancer and Environmental Toxicology . Her work spans Molecular Biology , Pharmacology , and Metabolic Pathways , particularly in targeting Kras-driven mutations and exploring anticancer compounds from fungi. Recent projects include modeling Environmental Pollutants and developing 3D-organoid systems for cancer drug testing. Key trends in her publications (2019–2025) include Lung Adenocarcinoma , Immune Checkpoint Inhibition , and Metabolic Reprogramming in cancer cells. She actively participates in LUCC workshops and Imaging/Nuclear Medicine seminars , both as a speaker and organizer.

• Cancer Genetics
• Hereditary Cancer Syndromes
• Genetic Epidemiology
• +5 more

Marie Stenmark Askmalm is a Researcher at Lund University Cancer Centre (LUCC) , a Supervisor in Paediatrics at Lund University, and a Consultant in Cancerepidemiology and Radiation. Her work focuses on hereditary cancer syndromes, particularly TP53-related disorders, BRCA1/BRCA2 mutations, and cancer risk assessment through genetic testing and imaging. She is affiliated with the Swedish Clinical TP53 Study Group (SweClinTP53) and contributes to national genomic medicine initiatives.

Urban FribergView profile

Professor

• Evolutionary Biology
• Genetics
• Ageing Research
• +3 more

Urban Friberg is a Professor at Linköping University's Department of Physics, Chemistry and Biology (IFM), within the Biology (BIOLO) division. His research focuses on evolutionary genetics, particularly the intersection of aging and sex differences in organisms like Drosophila melanogaster . Key areas include the genetic basis of aging, sexual dimorphism, genomic conflicts, and mutation effects across lifespans. His work has revealed how mutations influence aging differently with age, the desexualization of brain transcriptomes in aging fruit flies, and sex-specific lifespan strategies. Collaborations include researchers from institutions like Uppsala University, Monash University, and the University of Tennessee. He leads the Friberg Group and is affiliated with SciLifeLab Linköping , leveraging advanced life science technologies. Notable contributions include studies on X chromosome effects on lifespan and the role of diet in microbiota dynamics. Recent grants include VR funding for research projects in aging and genetics. His findings bridge evolutionary theory with molecular mechanisms, advancing understanding of aging and genomic conflicts.

Ulf KargénView profile

Assistant Professor

• Information Security
• Systems Security
• Software Security
• +4 more

Ulf Kargén is an Assistant Professor at Linköping University's Department of Computer and Information Science (IDA). His research focuses on information security, particularly systems and software security, with an emphasis on dynamic analysis of binary-code programs. He is a PhD student under the supervision of Professor Nahid Shahmehri, exploring topics such as scalable dynamic analysis methods and security flaw detection in software. He leads courses in software security (TDDC90) and information security (TDDD17) at Linköping University. His work includes developing tools like desync-cc for program obfuscation and analyzing Android app decompilation performance. He is part of the Security and Networks Group at ADIT, which emphasizes secure and reliable information systems. Key research areas include code obfuscation detection, malware analysis, and empirical studies of decompiler effectiveness. His publications span topics like autonomous vehicle compliance testing, binary code analysis, and compiler-level security mechanisms.

Dorota ReligaView profile

Professor

• Multimorbidity
• Frailty
• Dementia
• +3 more

Dorota Religa is a Professor and Senior Physician at Karolinska Institutet's Department of Neurobiology, Care Sciences and Society, where she leads the Dementia and Multimorbidity research group. She specializes in dementia, Alzheimer's disease, aging, and frailty, with a focus on registry-based studies using the Swedish Dementia Registry (SveDem) to improve care for patients with cognitive impairment and comorbidities. Her research examines diabetes-dementia interactions, blood biochemistry trajectories, antipsychotic treatments for behavioral symptoms, and multidisciplinary approaches to neurodegenerative disorders. She has supervised over 50 doctoral and master's students, including projects on cardiovascular comorbidities, caregiver mental health, and pharmacoepidemiology. Religa's recent publications focus on COVID-19 impacts in older adults, dementia care disparities, and novel diagnostic technologies. She collaborates internationally on projects like RADAR-AD for remote dementia monitoring. Grants supporting her work include funding from the Swedish Research Council, Stockholm County Council (ALF), Alzheimerfonden, and Horizon 2020. Her laboratory investigates modifiable risk factors in dementia, emphasizing clinical translation and health system improvements.